It was in 1817 that London physician James Parkinson first wrote a description of a movement disorder in a detailed medical essay entitled ‘An Essay on the Shaking Palsy’.
[Excerpt] “Involuntary tremulous motion, with lessened muscular power, in parts not in action and even when supported; with a propensity to bend the trunk forwards, and to pass from a walking to a running pace: the senses and intellects being uninjured.”
Affecting an estimated 145,519 people in UK* and seven to 10 million people worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety).
Even though research in the Parkinson’s disease field continues to progress, there is still no cure for this disease at the moment. There are too many challenges that researchers face in the field of Parkinson’s but some progress is being made as clinicians are beginning to understand the complexity of this disease. There is indeed a large, dedicated global community of researchers and clinicians that are investigating many new and potentially successful targets.
For example, the first machine in Europe that helps cure the tremor of Parkinson’s disease has been recently installed at the Borgo Trento Hospital in Verona, Italy. The machine, called MRgFus, allows non-invasive treatment of different types of diseases and uses ultrasound to destroy the alterations in benign tissue, without affecting healthy surrounding.
The machine seems to be able to treat the tremors of the Parkinson’s disease, in whole or in part, without invasiveness, without surgery, without pain and without side effects. It would act on the dominant tremors of Parkinson’s disease through focused ultrasounds guided by a Magnetic Resonance Imaging scan.**
New treatments or new specific machines start as an idea and sometimes the most innovative ideas carry the greatest amount of risk for investors because there is little reason or data to suggest that these initial concepts will translate into medications or other treatments to the benefit of patients. Funding for these new ideas is often difficult to find.
For this reason – and many other reasons – the Parkinson’s Disease Society UK and its other branches, such as the Parkinson’s Disease Society Isle of Man, welcome donations – any contributions will provide funds for financial, practical and emotional support to families and individuals, along with financing medical and scientific research aimed at understanding, treating and potentially curing the Parkinson’s disease.
Commenting on the recent donation, Paul Watterson, Director at Abacus, said: “As part of our company’s ongoing commitment to giving back and supporting our community, we have been grateful for the opportunity to support the Parkinson’s Disease Society Isle of Man, an organization that is making an impact and working hard to advance a greater good. The Parkinson’s Disease Society Isle of Man makes life better for local people with Parkinson’s disease by improving care and advancing research toward a cure.”
Whether it’s a one-off donation or a regular gift, everyone can help the Parkinson’s Disease Society Isle of Man aid local people with Parkinson’s and support the scientific research. If you would like to learn more or discover how to support, please visit www.parkinsons.im
* to find out more, read bit.ly/2Kx7Ai9
** to learn more, visit the Borgo Trento Hospital website www.ospedaleuniverona.it/ecm/home
[L-R] Lorraine Boyd and Kevin Loundes from Abacus are donating a cheque to Mrs Fiona Shimwell from Parkinson’s Disease Society Isle of Man.